logo
[breadcrumb_custom]

Tag: (VIR)

Industry

Vir Biotechnology Inc: Navigating Market Fluctuations with a 1.04B Market Cap

Vir Biotechnology Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $27.48 on 06/13/23, while the lowest price for the same duration was marked at $7.72 on 04/25/24. 52-week price history of VIR Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Vir Biotechnology Inc’s current trading price is -72.23% away from its 52-week high, while its distance from the 52-week low is -1.17%. The stock’s price range during this period has spanned from $7.72 to $27.48. In the Healthcare

OPEN Stock
Industry

VIR’s 2023 Market Dance: Down -20.87% – Time to Invest?

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded a decrease of -20.87%. However, over the last six months, the performance has been stronger by -6.90%. The price of VIR decreased -20.40% over the last 30 days. And in the last five days, it has fallen by -13.85%. Vir Biotechnology Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $27.48 on 06/13/23, and the lowest price during

Finance

Vir Biotechnology Inc (VIR) Stock: Navigating a Year of Volatility

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Vir Biotechnology Inc’s current trading price is -63.61% away from its 52-week high, while its distance from the 52-week low is 29.53%. The stock’s price range for this period has been between $7.72 and $27.48 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.35 million for the day, a number notably higher than the average daily volume of 1.12 million over the last three months. Vir Biotechnology Inc ‘s stock market performance